ArticleHead & neck2019

Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.

Cheng-Yu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.